Filing Details

Accession Number:
0001209191-12-031975
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-04 16:51:51
Reporting Period:
2012-05-22
Filing Date:
2012-06-04
Accepted Time:
2012-06-04 16:51:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339455 Somaxon Pharmaceuticals Inc. SOMX Pharmaceutical Preparations (2834) 200161599
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1173408 L.p. Iii Bioventures Mpm C/O Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1173409 L.p. Iii-Qp Bioventures Mpm C/O Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1249063 Mpm Bioventures Iii Parallel Fund, L.p. C/O Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1249133 Mpm Bioventures Iii Gmbh & Co. Beteiligungs Kg C/O Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1249143 L.p. Gp Iii Bioventures Mpm C/O Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1249147 Mpm Bioventures Iii Llc C/O Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
1346986 Mpm Asset Management Investors 2005 Bviii Llc C/O Mpm Asset Management
200 Clarendon St., 54Th Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-05-22 287,000 $0.30 4,345,562 No 4 S Indirect See Footnote
Common Stock Disposition 2012-05-23 135,250 $0.30 4,210,312 No 4 S Indirect See Footnote
Common Stock Disposition 2012-05-25 293,015 $0.30 3,917,297 No 4 S Indirect See Footnote
Common Stock Disposition 2012-05-29 15,300 $0.30 3,901,997 No 4 S Indirect See Footnote
Common Stock Disposition 2012-05-30 51,007 $0.30 3,850,990 No 4 S Indirect See Footnote
Common Stock Disposition 2012-05-31 29,850 $0.30 3,821,140 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. The shares were sold as follows: 239,235 by MPM BioVentures III-QP, L.P. ("BV III QP"), 16,086 by MPM BioVentures III, L.P. ("BV III"), 4,236 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 7,227 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 20,216 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
  2. The shares are held as follows: 3,622,311 by BV III QP, 243,568 by BV III, 64,163 by AM 2005, 109,419 by BV Parallel and 306,101 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  3. The shares were sold as follows: 112,740 by BV III QP, 7,581 by BV III, 1,996 by AM 2005, 3,406 by BV Parallel and 9,527 by BV KG.
  4. The shares are held as follows: 3,509,571 by BV III QP, 235,987 by BV III, 62,167 by AM 2005, 106,013 by BV Parallel and 296,574 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  5. The shares were sold as follows: 244,249 by BV III QP, 16,423 by BV III, 4,325 by AM 2005, 7,378 by BV Parallel and 20,640 by BV KG.
  6. The shares are held as follows: 3,265,322 by BV III QP, 219,564 by BV III, 57,842 by AM 2005, 98,635 by BV Parallel and 275,934 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  7. The shares were sold as follows: 12,754 by BV III QP, 857 by BV III, 226 by AM 2005, 385 by BV Parallel and 1,078 by BV KG.
  8. The shares are held as follows: 3,252,568 by BV III QP, 218,707 by BV III, 57,616 by AM 2005, 98,250 by BV Parallel and 274,856 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  9. The shares were sold as follows: 42,518 by BV III QP, 2,859 by BV III, 753 by AM 2005, 1,284 by BV Parallel and 3,593 by BV KG.
  10. The shares are held as follows: 3,210,050 by BV III QP, 215,848 by BV III, 56,863 by AM 2005, 96,966 by BV Parallel and 271,263 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  11. The shares were sold as follows: 24,882 by BV III QP, 1,673 by BV III, 440 by AM 2005, 752 by BV Parallel and 2,103 by BV KG.
  12. The shares are held as follows: 3,185,168 by BV III QP, 214,175 by BV III, 56,423 by AM 2005, 96,214 by BV Parallel and 269,160 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.